SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-23-028002
Filing Date
2023-10-10
Accepted
2023-10-10 20:20:58
Documents
2
Period of Report
2023-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1551
2 poa_mcfarlane.htm EX-24 7142
  Complete submission text file 0001437749-23-028002.txt   10257
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RETROPHIN, INC. 12255 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address
McFarlane Neil F. (Reporting) CIK: 0001681098 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36913 | Film No.: 231319202